Influenzinum
- Product NDC
- 0220-5181
- 11-digit product format
- 002205181
- Labeler code
- 0220
- Product ID
- 0220-5181_5bae34b2-7556-b275-e063-6294a90a11ec
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- Dosage form
- PELLET
- Route
- ORAL
- Labeler
- Boiron
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2026-09-14
- Substance
- INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- Active strength
- 8; 8; 8 [hp_X]/8[hp_X]; [hp_X]/8[hp_X]; [hp_X]/8[hp_X]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Influenzinum
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) | 8 [hp_X]/8[hp_X] |
| INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) | 8 [hp_X]/8[hp_X] |
| INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) | 8 [hp_X]/8[hp_X] |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0220-5181-41 | 00220518141 | 8 [hp_X] in 1 TUBE (0220-5181-41) | 2026-09-14 | No | No | Current |